Biotech · Private company
Klus Pharma Inc.
Track this companyFree. Adds Klus Pharma Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- A166Phase 2 · HER2-positive Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- SKB264Phase 2 · Epithelial Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- SKB264Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid TumorsPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 17, 2023ClinicalTrials.gov NCT05642780 · fetched Nov 12, 2026
- Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 28, 2020ClinicalTrials.gov NCT04152499 · fetched Nov 12, 2026
- Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GenePHASE1_PHASE2 · COMPLETED · started Jul 16, 2018ClinicalTrials.gov NCT03602079 · fetched Nov 12, 2026